CIK 0001771910 · Non-accelerated filer<br>Smaller reporting company
ADC Therapeutics SA
Sign in to watch- Ticker
- ADCT
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- Phone
- 41 21 653 02 00
- Business address
- BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, Switzerland, 1066
- 4 Other disposition See Explanations disposed of 451,856 shares (other)
- 4 Shares withheld for taxes Chief Executive Officer gave up 26,758 shares (to pay taxes)
- 4 Grant or award Chief Legal Officer acquired 220,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 230,000 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 41,900 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 240,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 650,000 shares (grant or award)
- 4 Open-market buy 10% owner bought 200,000 shares at an average $3.05 ($609,000)
- 4 Shares withheld for taxes Chief Medical Officer gave up 37,112 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 6,503 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 48,108 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 41,458 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 238,343 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 25,352 shares at $2.07 ($52,479)
- 4 Open-market buy 10% owner bought 800,000 shares at $2.81 ($2,248,000)
- 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
- 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
- 4 Open-market sale Director sold 1,193 shares at $2.89 ($3,448)
- 4 Open-market sale Director sold 1,437 shares at $2.89 ($4,153)
- 4 Open-market sale Director sold 1,437 shares at $2.89 ($4,153)
Page 3 of 5 · 88 filings